NCT00231582View on ClinicalTrials.gov

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Testicular Neoplasms
Interventions
DRUG

epirubicin

epirubicin

PROCEDURE

high-dose and autologous stem cell transplantation

high-dose and autologous stem cell transplantation

DRUG

paclitaxel

paclitaxel

DRUG

etoposide

etoposide

DRUG

ifosfamide

ifosfamide

DRUG

carboplatin

carboplatin

Trial Locations (1)

75020

Hôpital TENON, Service d'Oncologie Médicale, Paris

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Amgen

INDUSTRY

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER